PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.04%
Revenue decline while VET shows 11.70% growth. Joel Greenblatt would examine competitive position erosion.
11.47%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
-35.12%
Gross profit decline while VET shows 55.04% growth. Joel Greenblatt would examine competitive position.
-22.73%
Margin decline while VET shows 38.79% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-9.90%
G&A reduction while VET shows 7.67% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-325.00%
Other expenses reduction while VET shows 3818.87% growth. Joel Greenblatt would examine efficiency.
-4.67%
Operating expenses reduction while VET shows 7.74% growth. Joel Greenblatt would examine advantage.
2.94%
Total costs growth while VET reduces costs. John Neff would investigate differences.
-11.11%
Interest expense reduction while VET shows 1.84% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-89.51%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
905.67%
EBITDA margin growth exceeding 1.5x VET's 5.54%. David Dodd would verify competitive advantages.
-142.19%
Operating income decline while VET shows 151.16% growth. Joel Greenblatt would examine position.
-150.25%
Operating margin decline while VET shows 145.80% growth. Joel Greenblatt would examine position.
-192.03%
Other expenses reduction while VET shows 56.88% growth. Joel Greenblatt would examine advantage.
-166.23%
Both companies show declining income. Martin Whitman would check industry conditions.
-178.88%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-51.61%
Both companies reducing tax expense. Martin Whitman would check patterns.
-188.64%
Net income decline while VET shows 72.15% growth. Joel Greenblatt would examine position.
-205.57%
Net margin decline while VET shows 75.06% growth. Joel Greenblatt would examine position.
-188.65%
EPS decline while VET shows 71.67% growth. Joel Greenblatt would examine position.
-188.65%
Diluted EPS decline while VET shows 72.17% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.